Cargando…
The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia
Platelet transfusion is the standard treatment to control or prevent bleeding in patients with Glanzmann's thrombasthenia (GT), but platelets are often unavailable. Recombinant activated factor VII (rFVIIa) is an effective alternative to platelets in patients with GT with past/present refractor...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Georg Thieme Verlag KG
2021
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895543/ https://www.ncbi.nlm.nih.gov/pubmed/33124022 http://dx.doi.org/10.1055/s-0040-1718373 |